Biolase Technology, Inc. (BLTI) Posts Second Consecutive Breakeven Quarter, Raises Q2 Revenue Guidance

Go back to Biolase Technology, Inc. (BLTI) Posts Second Consecutive Breakeven Quarter, Raises Q2 Revenue Guidance
Biolase Technology, Inc. (NASDAQ: BLTI) Delayed: 2.42 +0.06 (2.54%)
Previous Close $2.36    52 Week High $6.13 
Open $2.36    52 Week Low $2.14 
Day High $2.49    P/E N/A 
Day Low $2.36    EPS $-0.17 
Volume 80,153